“While the seminar provides some hope for manufacturers with pending Class C and D MA License applications, we won’t know if the new processes are actually put into place until at least October.”

David Vo
General Manager
Asia Actual Vietnam

Come grow with us in the US in Thailand in China in Korea in the Philippines in Taiwan in Hong Kong

Sources and Links

Sign Up For Our Newsletter to Stay Informed

Sign Up

Vietnam’s DMEC Provides Update on Issuance of Class C and D MA Licenses

Published on: September 14th, 2022

UPDATE: New Decree Issued March 3, 2023

Please click here to learn about the latest official guidance regarding import licenses in Vietnam. 

Extends Existing Import License Validity and CSDT Grace Period

This information may be outdated. Please see the link above for the latest information.

On September 14, 2022, the Department of Medical Equipment and Construction (DMEC) of the Ministry of Health (MOH) held a seminar to update the medical device industry on the issuance of Class C and D MA Licenses. The seminar comes 9 months into the new Vietnamese regulations outlined in Decree 98/2021 and no Class C or D Market Authorization (MA) Licenses have been issued. At the seminar the DMEC announced several steps they plan to implement in order to expedite the review of Class C and D MA applications and clear the backlog of pending applications. Not only has the delay in issuance of C and D MA Licenses frustrated medical device manufacturers, it has also created issues within the Vietnamese healthcare system as hospitals

Primary updates include:

  • Import Licenses are being automatically exteneded 1 more year to the end of 2023
  • CSDT documentation requirements are also being delayed 1 more year to January 1, 2024
  • The approval process is being updated. If the new process is applied in September 2022, DMEC expects that they will issue MA licenses to clear out the backlog of C and D applications. More information on the implementation is expected in October.
    • MA License review process for Class C and D Licenses
      • Step 1: 2 legal experts appraise the dossier; (according to new proposed process, this step will become a post-market activity)
      • Step 2: The reviewer summarizes the appraisal content;
      • Step 3: Submit to the Advisory Council for consideration;
      • Step 4: Ministry leaders sign and release.
  • 1 product can be have both, a valid Import License & a MA license in 2023, both license can be used in parallel.
  • Decree 98/2021, Circular 19/2021, Circular 14/2020 will be amended & modified in the coming months to reflect these changes

Overview of New Medical Device Requirements in Vietnam

The Vietnamese MOH implemented new requirements for medical devices on January 1, 2022 in accordance with Decree 98/2021. While it provided immediate registration for Class A and B products, Class C and D applications have been marred with delays due to internal interruptions at the MOH and have not been issued as of September 2022.

Some of the main highlights from the new requirements include:

  1. All Class B devices (not covered by a valid Import License) must have a MA License to be imported from Jan 1, 2022. (Note: Class A devices have required an MA License since Jan 1, 2020.) Class A and B MA Licenses are issued within 1 week of application submission.
  2. Class C and D devices (not covered by a valid Import License) that are listed in Circular 30/2015 (link to list here), must have a MA License to be imported from Jan 1, 2022.
  3. Class C and D devices that are not listed in Circular 30/2015, can be imported with a Classification Certificate until Dec 31, 2022 after which a MA License will be required.
  4. Class B MA License application have the same requirements as Class A devices starting Jan 1, 2022.
  5. For Class C and D devices with reference country approval, the technical review is waived. MOH application target proceeding time will be 10 days with reference country approval. (Note: China and Korea have been added to the US, Europe, Japan, Australia and Canada as reference countries.)
  6. MA Licenses will be issued without an expiration date (instead of the previous 5-year validity period).
  7. Registration Holders do not need to be the initial importer; and multiple importers/distributors can be authorized under the same MA license.

For more information on the registration process in Vietnam, please see our page on the topic here.

Application Fees and Target Review Times in Vietnam

Class DMEC Fees Standard Review Time Review Time w/ Reference Country Approval
A VND 1 million US$43 Within 5 days Within 5 days
B VND 3 million
Within 5 days Within 5 days
C VND 5 million
60 days* 10 days*
D VND 5 million
60 days* 10 days*

*MA Licenses have not been issued for Class C or D applications since the new regulations were implemented and therefore, Review Times for Class C and D applications are not accurate at this time. 

Come Grow With Us

Asia Actual specializes in helping medical device manufacturers grow their sales in Asia with experienced, bi-lingual commercial and regulatory experts on the ground in each market.

Contact Asia Actual today with any questions on how the rocky implementation of Decree 98/2021 may affect your business.

Blog Posts

CDSCO Issues Updates to IVD Classification List in India

The Central Drugs Standard Control Organisation (CDSCO) of India issued a notice (PDF) on October 25, 2023 classifying in-vitro diagnostic (IVD) medical devices under medical device rules. The updates to IVD classification in India include intended use, associated risk, and other parameters.

Embracing Innovation and Collaboration: Highlights from the 15th CII Global MedTech Summit

On October 6, 2023, a team of enthusiastic members from the AAI (Artificial Intelligence and Innovation) group, including Ashoniya Puri, Sanjay Singh, and Rajat Budhori, had the honor of attending the prestigious 15th CII Global MedTech Summit. Hosted by the Confederation of Indian Industry (CII), one of India's largest industry bodies, this event brought together key players in the MedTech sector, both from India and abroad. The summit revolved around the central theme, "Paving the way for a USD 50 billion MedTech Industry by 2030," signifying a collective vision for the industry's future growth.


On September 18, 2023, The Directorate General of Drug Administration (DGDA) published the Drug and Cosmetics Act 2023 formalizing the regulatory requirements of medical and diagnostic devices in Bangladesh with immediate effect.  A translated version of the document is available on Asia Actual’s website here.  All medical devices now require a Marketing Authorization Certificate to clear Customs and be sold on the market in Bangladesh.